Increased blood volume and CD34+CD38- progenitor cell recovery using a novel umbilical cord blood collection system

Stem Cells

Volumn 18, Issue 4, 2000, Pages 245-251

  Belvedere, Ornella ^a   Feruglio, Cristina ^a   Malangone, Walter ^a   Bonora, Maria L ^a   Minisini, Alessandro M ^a   Spizzo, Riccardo ^a   Donini, Annibale ^b   Sala, Pierguido ^a   De Anna, Dino ^b   Hilbert, David M ^c   Degrassi, Alberto ^a,d  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c GLAXOSMITHKLINE   (United States)

^d c/o Padiglione Petracco ^*  (Italy)

Author keywords

CD34; CD38; Device; Hematopoietic stem cells; Umbilical cord blood; Umbilical cord blood collection

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; CELL COUNT; CELL DENSITY; CELL SUBPOPULATION; DEVICE; HEMATOPOIETIC STEM CELL; KINETICS; PLACENTA; STEM CELL; UMBILICAL CORD BLOOD;

EID: 0033867240     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.18-4-245     Document Type: Article

References (27)

1. Thompson C. Umbilical cords: turning garbage into clinical gold. Science 1995;268:805-806.
2. Wagner JE, Kernan NA, Steinbuch M et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 1995;346:214-219.
3. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-166.
4. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-381.
5. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665-4678.
6. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-1577.
7. McCullough J, Herr G, Lennon S et al. Factors influencing the availability of umbilical cord blood for banking and transplantation. Transfusion 1998;38:508-510.
8. Yao AC, Lind J. Placental transfusion. Am J Dis Child 1974;127:128-141.
9. Donaldson C, Armitage WJ, Buchanan RM et al. Obstetric factors influencing cord blood collections. Blood 1998;92:121a.
10. Shlebak AA, Roberts IAG, Stevens TA et al. The impact of antenatal and perinatal variables on cord blood haemopoietic stem/progenitor cell yield available for transplantation. Br J Haematol 1998;103:1167-1171.
11. Bertolini F, Lazzari L, Lauri E et al. Comparative study of different procedures for the collection and banking of umbilical cord blood. J Hematother 1995;4:29-36.
12. Wagner JE, Broxmeyer HE, Cooper S. Umbilical cord and placental blood hematopoietic stem cells: collection, cryopreservation, and storage. J Hematother 1992;1:167-173.
13. Rubinstein P, Rosenfield RE, Adamson JW et al. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993;81:1679-1690.
14. Harris DT, Schumacher MJ, Rychlik S et al. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant 1994;13:135-143.
15. Request for proposed standards for unrelated allogeneic peripheral and placental/umbilical cord blood hematopoietic stem/progenitor cell products; request for comments. United States Food and Drug Administration, Docket No. 97N-0497, January 20, 1998.
16. Yin AH, Miraglia S, Zanjani ED et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-5012.
17. Miraglia S, Godfrey W, Yin AH et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997;90:5013-5021.
18. + hematopoietic stem and progenitor cells. Cytometry 1998;34:128-142.
19. Roodman GD, LeMaistre CF, Clark GM et al. CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy. Bone Marrow Transplant 1987;2:165-173.
20. - progenitor cells. Blood 1991;77:1218-1227.
21. - cells in cord blood and bone marrow. Blood 1995;86:3745-3753.
22. - hematopoietic stem cells. Blood 1994;83:1515-1526.
23. - cells with both lymphoid and myeloid potential. Blood 1998;91:4145-4151.
24. - cells. Blood 1998;91:1966-1976.
25. Emerson SG. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood 1996;87:3082-3088.
26. + cord blood cells. Blood 1999;93:1097-1105.
27. Nolta JA, Kohn DB. Hematopoietic stem cells for gene therapy. In: Potter CS, ed. Stem Cells. San Diego, CA: Academic, 1996:447.